[Federal Register Volume 74, Number 180 (Friday, September 18, 2009)]
[Notices]
[Page 47961]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-22506]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration

    By Notice dated June 22, 2009, and published in the Federal 
Register on June 26, 2009, (74 FR 30621), Noramco, Inc., Division of 
Ortho-McNeil, Inc., 500 Swedes Landing Road, Wilmington, Delaware 
19801, made application by letter to the Drug Enforcement 
Administration (DEA) to be registered as an importer of Tapentadol 
(9780), a basic class of controlled substance listed in schedule II.
    The company plans to import an intermediate of the basic class 
listed for the bulk manufacture of Tapentadol which it will distribute 
to its customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and Sec.  952(a) and determined that 
the registration of Noramco, Inc. to import the basic class of 
controlled substance is consistent with the public interest and with 
United States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971, at this time. DEA has investigated 
Noramco, Inc. to ensure that the company's registration is consistent 
with the public interest. The investigation has included inspection and 
testing of the company's physical security systems, verification of the 
company's compliance with State and local laws, and a review of the 
company's background and history. Therefore, pursuant to 21 U.S.C. 
952(a) and Sec.  958(a), and in accordance with 21 CFR 1301.34, the 
above named company is granted registration as an importer of the basic 
class of controlled substance listed.

    Dated: September 14, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E9-22506 Filed 9-17-09; 8:45 am]
BILLING CODE 4410-09-M